What should researchers and recipients be aware of regarding ClinicalTrials.gov as it relates to reporting NIH grant-funded trials? Join us for this episode of the NIH All About Grants podcast to hear from Dr. Anna Fine, the Acting Director of ClinicalTrials.gov.
NIH recently updated its annual categorical information with fiscal year (FY) 2022 actual spending data and estimates for FY 2023 and 2024.
0 Comments
We are discussing “Not Discussed” in this NIH All About Grants podcast.
0 Comments
This NIH All About Grants podcast episode walks through the timelines you should keep in mind when preparing an NIH grant application.
2 Comments
Join us for this episode of the NIH All About Grants podcast to learn more about the format, frequency, and timing of RCR instruction.
0 Comments
NIH supports Phase III trials to study how effective interventions are in large groups of people, comparing them to other standard or experimental interventions. We go deeper into these clinical trials and what you should know in our next edition of the NIH All About Grants podcast.
0 Comments
NIH expects that sex as a biological variable (SABV) will be factored into research designs, analyses, and reporting in pre-clinical and clinical studies. But, how exactly do you account for SABV? Dr. Chyren Hunter with the NIH Office of Research on Women’s Health explains more in this NIH All About Grants podcast episode.
0 Comments
This NIH All About Grants podcast episode delves into what you should consider when working with OLAW in obtaining an animal welfare assurance.
0 Comments
NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2021 actual spending data and estimates for FY 2022 and 2023. There are now 309 total RCDC publicly reported categories.
0 Comments
Join us for this NIH All About Grants podcast episode to learn more about R56/bridge awards. Drs. Lakshmi Ramachandra from the National Institute of Allergy and Infectious Diseases and Bonnie Burgess-Beusse with the National Institute of Diabetes and Digestive and Kidney Diseases will tell us about the purpose of bridge awards, how program staff consider who and what to recommend for funding, the budget, when investigators should reach out about them, and more.
0 Comments
0 Comments